AXSM Exercise Disclosure
Tabuteau Herriot · SEC Form 4 · Filed Aug 7, 2026
Exercise
Calculated transaction value
$23.07K
Tabuteau Herriot Chief Executive Officer
AXSM
Axsome Therapeutics
AXSM
Transaction date
Aug 6, 2026
Public filing date
Aug 7, 2026
Filing lag
Filed 1 day later
AXSM daily price context
Close on/before transaction
$210.13
Aug 6, 2026
Close before public filing
$210.13
Aug 6, 2026
Return since public filing
-1.97%
Through Sep 15, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 4,660 shares @ $4.95
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001193125-26-340688
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
1
Estimated value
$10.78M
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Axsome Therapeutics, Inc. AXSM | Sale | Aug 6, 2026 | $997.01K |
| Axsome Therapeutics, Inc. AXSM | Exercise | Aug 6, 2026 | $0 |
| Axsome Therapeutics, Inc. AXSM Current | Exercise | Aug 6, 2026 | $23.07K |
| Axsome Therapeutics, Inc. AXSM | Exercise | Aug 5, 2026 | $0 |
| Axsome Therapeutics, Inc. AXSM | Sale | Aug 5, 2026 | $9.54M |
| Axsome Therapeutics, Inc. AXSM | Exercise | Aug 5, 2026 | $222.77K |